Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have identified a list of proteins with significant, >2-fold change in abundance following our manipulations, of which PARK7/DJ-1 - an anti-oxidant implicated in hereditary forms of Parkinson's Disease (PD), and DPYSL2/CRMP-2 - a microtubule-binding phosphoprotein involved in schizophrenia pathogenesis - were both found to have measurable effects on neuronal homeostasis and phenotype.
|
30562574 |
2019 |
Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results support the functional importance of the DPYSL2 DNR and a role for mTOR signaling in schizophrenia.
|
27801893 |
2016 |
Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Taken together with previous studies investigating the association between the DPYSL2 gene and schizophrenia, the present findings may contribute additional evidence regarding developmental theories of the pathophysiology of schizophrenia.
|
25847191 |
2015 |
Schizophrenia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The DPYSL2 gene at 8p22-p21 is expressed widely in neuronal tissues and has been implicated in multiple psychiatric disorders such as Alzheimer's disease and schizophrenia.
|
23846846 |
2014 |
Schizophrenia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Further, several independent gene expression studies have shown that DPYSL2 is differentially expressed in SZ brains [Beasley et al.2006.
|
21302347 |
2011 |
Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conclude that DPYSL2 does not have a major function in SCZ in Japanese subjects.
|
20414250 |
2010 |
Schizophrenia
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.
|
19110265 |
2009 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We have previously demonstrated that the DRP-2 gene is associated with susceptibility to schizophrenia, but not to bipolar disorders.
|
17105906 |
2006 |
Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Case-control and TDT analyses were performed to detect association of DPYSL2 with schizophrenia.
|
16321170 |
2006 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
We conclude that the DRP-2 *2236 C allele may mark another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to schizophrenia.
|
15858820 |
2005 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We conclude that the DRP-2 *2236 C allele may mark another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to schizophrenia.
|
15858820 |
2005 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, we demonstrated a significant association between the DRP-2 gene and schizophrenia.
|
12951196 |
2003 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the *2236C allele in the 3'UTR of the DRP-2 gene, or an unknown mutation in linkage disequilibrium with this allele, may reduce the susceptibility to schizophrenia, especially the paranoid subtype.
|
12679234 |
2003 |